Rating Change
Guggenheim analysts initiated coverage on AN2 Therapeutics, Inc. (NASDAQ:ANTX) with a Buy rating on July 20, 2026.
new coverageNASDAQ:ANTX
Guggenheim Initiates Coverage on AN2 Therapeutics, Inc. (ANTX) with Buy
Rating Change Guggenheim analysts initiated coverage on AN2 Therapeutics, Inc. (NASDAQ:ANTX) with a Buy rating on July 20, 2026. Market Context AN2 Therapeutics, Inc.
Market Context
AN2 Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $4.90 with a market capitalization of $30.1M. The stock has gained 310.5% over the past 52 weeks.
Analyst coverage from Guggenheim provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for AN2 Therapeutics, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for AN2 Therapeutics, Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 20, 2026 | Guggenheim | Buy | N/A |
| May 14, 2026 | Leerink Partners | Outperform | N/A |
| May 05, 2025 | JMP Securities | Market Outperform | N/A |
| Mar 26, 2025 | Citizens Capital Markets | Market Outperform | N/A |
| Feb 25, 2025 | Citizens Capital Markets | Market Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View ANTX Stock Page
Frequently Asked Questions
What does a Buy rating mean for ANTX?
A Buy rating from Guggenheim reflects the analyst's outlook on AN2 Therapeutics, Inc. (NASDAQ:ANTX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ANTX forecast page.